Abstract: Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases or Celiac disease by modulating the binding of DQ8 MHC class II molecules to antigenic peptides or fragments of antigenic peptides.

Abstract: Methods of administering methyldopa to a subject in a fasting state to increase bioavailability of the methyldopa.

Abstract: Methods of administering methyldopa to a subject in a fasting state to increase bioavailability of the methyldopa.

Abstract: Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases or Celiac disease by modulating the binding of DQ8 MHC class II molecules to antigenic peptides or fragments of antigenic peptides.

Abstract: Methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease. The binding may be modulated by the administration of D-?-methyldopa, or pharmaceutical compositions comprising therapeutically effective amounts of D-?-methyldopa.

Abstract: Methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease. The binding may be modulated by the administration of D-?-methyldopa, or pharmaceutical compositions comprising therapeutically effective amounts of D-?-methyldopa.

Abstract: Methods and composition for treating or preventing, the occurrence of senile dementia of the Alzheimer's type, or other conditions arising from reduced neuronal metabolism and leading to lessened cognitive function are described. In a preferred embodiment the administration of novel esterified saccharide compounds to said patient at a level to produce an improvement in cognitive ability.

Abstract: The present invention is directed toward a process for producing zeaxanthin which includes mutating algal microorganisms, selecting from said mutated microorganisms a microorganism capable of producing zeaxanthin, culturing the selected microorganism in an effective medium to produce zeaxanthin, and recovering zeaxanthin produced by the selected microorganism. The present invention also provides microorganisms capable of producing zeaxanthin, formulations containing zeaxanthin produced by the disclosed process and the use of such formulations to enhance pigmentation and to reduce damage caused by reactive oxygen species and phototoxic molecules.

Abstract: Phenylalanine ammonia-lyase (PAL) producing Rhodotorula graminis, high PAL specific activity, strain GX 6000 its progeny, and PAL producing mutants thereof can be utilized for phenylalanine production from cinnamate. In this strain, PAL can be induced synergistically by phenylalanine and leucine or isoleucine.

Abstract: A yeast culture medium contains glucose, yeast extract, buffers, alkaline earth metal salts, and antibiotics, has a pH of 4.3 to 4.7. Yeast strains of the genus Rhodotorula, obtained from water and soil samples, are useful as desaturase enzymes, especially for the conversion of oleic acid to linoleic acid in improved yields using the yeast culture medium.

Abstract: A method of killing and inhibiting the growth of microorganisms in industrial process streams comprises the addition of an enzymatically catalyzed biocide system utilizing a microbial or plant dehydrogenase enzyme such as peroxidase or laccase in the presence of an oxidant such as hydrogen peroxide or oxygen to oxidize phenolic compounds found in or added to the process streams to produce oxidation products that are toxic to microorganisms.

Abstract: A method of killing and inhibiting the growth of microorganisms in industrial process streams comprises the addition of an enzymatically catalyzed biocide system utilizing a microbial or plant dehydrogenase enzyme such as peroxidase or laccase in the presence of an oxidant such as hydrogen peroxide or oxygen to oxidize halide salts, or phenolic compounds found in or added to the process streams to produce oxidation products that are toxic to microorganisms.